ACBM (Acro Biomedical Co) Liabilities-to-Assets : 112.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acro Biomedical Co Liabilities-to-Assets?

Acro Biomedical Co ACBM Liabilities-to-Assets is 112.00 as of Jun. 2026. The stock has 2 warning signs investors should review.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Acro Biomedical Co's Total Liabilities for the quarter that ended in Jun. 2026 was $0.45 Mil. Acro Biomedical Co's Total Assets for the quarter that ended in Jun. 2026 was $0.00 Mil.

Acro Biomedical Co  (OTCPK:ACBM) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Acro Biomedical Co Liabilities-to-Assets Related Terms

Acro Biomedical Co Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Acro Biomedical Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co Liabilities-to-Assets Chart

Acro Biomedical Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.29 5.43 10.22 28.64

Acro Biomedical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 109.25 28.64 107.75 112.00

ACBM vs RNGC, EEGI, AGIN: Liabilities-to-Assets Comparison

For the Shell Companies subindustry, Acro Biomedical Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co Liabilities-to-Assets vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Acro Biomedical Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Liabilities-to-Assets falls into.


Acro Biomedical Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Acro Biomedical Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

Liabilities-to-Assets (A: Dec. 2025 )=Total Liabilities/Total Assets
=0.401/0.014
=28.64

Acro Biomedical Co's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 is calculated as

Liabilities-to-Assets (Q: Jun. 2026 )=Total Liabilities/Total Assets
=0.448/0.004
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 112.00 mean?
Acro Biomedical Co (ACBM) has a Liabilities-to-Assets of 112.00 as of Jun. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Acro Biomedical Co and its competitors.
Is Acro Biomedical Co's Liabilities-to-Assets too high?
Acro Biomedical Co's current Liabilities-to-Assets is 112.00.
How does Acro Biomedical Co's Liabilities-to-Assets compare to RNGC and EEGI?
Acro Biomedical Co's Liabilities-to-Assets of 112.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Diversified Financial Services company?
A good Liabilities-to-Assets depends on the Diversified Financial Services industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Acro Biomedical Co and its competitors. Acro Biomedical Co's current Liabilities-to-Assets is 112.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current Liabilities-to-Assets of 112.00. The current Liabilities-to-Assets is 112.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current Liabilities-to-Assets is 112.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acro Biomedical Co Business Description

Address 12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd is a shell company.